ebomi
Colour theme
Sign in
Insider · CIK 0001288452

BAY City Capital LLC

CIK 0001288452 Name as filed on the most recent filing

Filed as BAY City Capital LLC (34)

127 transaction lines · from 34 filings · filed 2007-04-30 to 2021-10-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

4 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2013-05-28 S, Open-market sale Hyperion Therapeutics IncHPTX 4,722, disposed Open Form 4 filing 0001181431-13-031712
2013-05-20 S, Open-market sale Hyperion Therapeutics IncHPTX 2 lines 44,480, disposed Open Form 4 filing 0001181431-13-029568
2013-05-17 S, Open-market sale Hyperion Therapeutics IncHPTX 2 lines 2,937,334, disposed Open Form 4 filing 0001181431-13-029568
2011-09-23 P, Open-market purchase EnteroMedics IncETRM 2 lines 1,386,000, acquired Open Form 4 filing 0001181431-11-050461
2010-12-14 P, Open-market purchase EnteroMedics IncETRM 2 lines 2,958,000, acquired Open Form 4 filing 0001181431-10-062284
2010-06-30 P, Open-market purchase Sunesis Pharmaceuticals IncSNSS 2 lines 6,551,724, acquired Open Form 4 filing 0001209191-10-036694
2009-02-19 P, Open-market purchase EnteroMedics IncETRM 2 lines 1,896,908, acquired Open Form 4 filing 0001181431-09-010525
2008-10-24 P, Open-market purchase EnteroMedics IncETRM 2 lines 54,560, acquired Open Form 4 filing 0001181431-08-058526
2008-04-29 P, Open-market purchase EnteroMedics IncETRM 2 lines 112,500, acquired Open Form 4 filing 0001181431-08-027650
2008-04-24 P, Open-market purchase EnteroMedics IncETRM 2 lines 225,000, acquired Open Form 4 filing 0001181431-08-026875
2008-02-29 P, Open-market purchase EnteroMedics IncETRM 2 lines 181,860, acquired Open Form 4 filing 0001181431-08-016060
2007-11-15 P, Open-market purchase EnteroMedics IncETRM 2 lines 3,000,000, acquired Open Form 4 filing 0001181431-07-070480
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 346,531, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 69,307, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 13,853, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 7,469, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 2,254, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 1,257, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 557, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 449, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 254, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 115, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 86, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 46, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 17, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 17, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 6, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 6, acquired Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD Not reported Open Form 4 filing 0001181431-07-055376
2007-08-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD Not reported Open Form 4 filing 0001181431-07-055376
2007-08-29 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 6 lines 28,381, acquired Open Form 4 filing 0001181431-07-055372
2007-08-16 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 19,862, acquired Open Form 4 filing 0000898430-07-003033
2007-08-16 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 3,970, acquired Open Form 4 filing 0000898430-07-003033
2007-08-16 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 795, acquired Open Form 4 filing 0000898430-07-003033

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BAY CITY CAPITAL LLC, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001288452

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.